Effect of VEGF and minoxidil on the production of arachidonic acid metabolites by cultured hair, dermal papilla cells

European Journal of Dermatology

Volumn 6, Issue 5, 1996, Pages 365-368

  Lachgar, Souâd ^a,b   Charvéron, Marie ^a,b   Ariès, Marie Françoise ^a,b   Pipy, Bernard ^a   Gall, Yvon ^b   Bonafé, Jean Louis ^a  

^a CHU RANGUEIL   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Arachidonic acid metabolites; Dermal papilla cells; Hair; LTB4; Minoxidil; PG6KF(1 ); PGE2; VEGF

Indexed keywords

ARACHIDONIC ACID; CALCIMYCIN; LEUKOTRIENE B4; MINOXIDIL; PHORBOL ESTER; PHOSPHOLIPID; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; VASCULOTROPIN;

ALOPECIA; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HAIR GROWTH; NONHUMAN; RAT;

EID: 0029901139     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Westgate GE, Graggs RI, Gibson WT. Immune privilege in hair growth. J Invest Dermatol 1991; 97: 417-20.
2. Li L, Margolis LB, Paus R, Hoffmann RM. Hair shaft elongation, follicle growth, and spontaneous regression in long-term, gelatin sponge-supported histoculture of human scalp skin. Proc Natl Acad Sci USA 1992; 89: 8764-8.
3. Parakkal PF. Catagen and telogen phases of the growth cycle. In: Orfanos CE, Hopple R, eds. Hair and hair diseases. Berlin: Springer-Verlag, 1990: 99-116.
4. Gibson WT, Westgate GE, Craggs RI. Immunology of the hair follicle. Ann NY Acad Sci 1991; 642: 291-300.
5. Jahoda CAB, Oliver RF. The dermal papilla and the growth of hair. In: Orfanos CE, Hopple R, eds. Hair and hair diseases. Berlin: Springer-Verlag, 1990: 19-44.
6. 4 and its ω-oxidation products. Prostaglandins 1986; 31: 851-9.
7. Salomon LM, Juhlin L, Kirchenbaum MB. Prostaglandins on cutaneous vasculature. J Invest Dermatol 1968; 51: 280-2.
8. Goodwin JS, Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol 1983; 3: 295-315.
9. + permeability. J Pharm Exp Ther 1988; 245: 751-60.
10. Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 1986; 15: 30-7.
11. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
12. Higgs GA. The role of eicosanoids in inflammation. Prog Lipid Res 1986; 25: 555-61.
13. Ruzicka T. The physiology and pathophysiology of eicosanoids in the skin. Eicosanoids 1988; 1: 59-72.
14. Chan CC, Ford-Hutchinson A. Effects of systemic leukotrienes on local blood flow and vascular permeability in porcine skin. J Invest Dermatol 1985; 84: 154-7.
15. Scott WA, Pawlowski NA, Murray HW, Andreach M, Zrrike J, Cohn ZB. The regulation of arachidonic acid metabolism by macrophage activation. J Exp Med 1982; 155: 1148-61.
16. 4 induces in vitro fibroblast chemotaxis. J Invest Dermatol 1984; 82: 9-13.
17. Johoda C, Oliver RF. The growth of vibrissa dermal papilla cells in vitro. Br J Dermatol 1981; 110: 685-9.
18. Forgue MF, Pipy B, Beraud M, Souqual MC, Combis JM. 1-Naphthyl-N-methyl carbamate effect on intra- and extracellular concentrations of aracnidonic acid metabolites, and on the chemiluminescence generation by mouse peritoneal macrophages. Int J Immunopharmacol 1990; 12: 155-63.
19. Forgue MF. Influence des molécules immunomodulatrices dans la production de prostaglandines et leucotriènes par le macrophage en culture. Thesis, University of Toulouse III, France, 1989.
20. Forgue-Ariès MF, Charvéron M, Pipy B, Bonafé JL, Gall Y. Production of cyclooxygenase and lipoxygenase metabolites by cultured human keratinocytes. Nouv Dermatol 1993; 12: 504 (abstr).
21. Ziehe M, Jones J, Gullino PM. Role or prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 1982; 69: 475-82.
22. Voelker NF. Role of platelet-derived growth factor and other growth factors in inflammation. In: Henson PM, Murphy B, eds. Mediators of the inflammatory process. Amsterdam: Elsevier Sciences Publisher, 1989: 45-56.
23. Kuwashima L, Greaber J, Glaser B. Stimulation of endothelial cell prostacyclin release by retina-derived growth factors. Ophthalmol Vis Sci 1988; 29: 1213-20.
24. Wecksler BB. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthetase and prostacyclin synthetase. J Cell Physiol 1990; 142: 514-22.
25. Kvedar J, Baden HP, Levine L. Selective inhibition by minoxidil of prostacyclin production by cells in culture. Biochem Pharmacol 1988; 37: 867-74.
26. Hecker M, Ullrich V. Studies of the interaction of minoxidil with prostacyclin synthase in vitro. Biochem Pharmacol 1988; 37: 3363-5.
27. Bikfalvi A, Sauseau C, Moukadiri H, Maclouf J, Busso N, Bryckaert M, Plouët J, Tobelem G. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells. Binding, internalization, degradation, and biological effects. J Cell Physiol 1991; 149: 50-9.
28. Lachgar S, Moukadiri H, Jonca F, Charvéron M, Gall Y, Bonafé JL, Plouët J. VEGF is an autocrine growth factor for cultured hair dermal papilla cells. J Invest Dermatol 1996; 106: 17-23.
29. Praloran V, Mirshahi S, Favard C, Moukadiri H, Plouët J. Lymphokine activity of vasculotropin. C R Acad Sci, Paris, Sér III 1991; 313: 21-6.
30. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Conolly DT, Stern D. Vascular permeability factor, a tumorderived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-46.